跳至主要内容
临床试验/NCT07427485
NCT07427485进行中(未招募)不适用

Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study

Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40
试验地点
1
主要终点
Positive and Negative Syndrome Scale (PANSS)

研究概览

简要总结

Virtual reality-based rehabilitation has recently gained increasing attention in the field of cognitive rehabilitation, allowing patients to engage in simulated real-life scenarios within a safe and controlled setting. The feasibility and safety of immersive VR-based cognitive rehabilitation in individuals with schizophrenia is currently insufficiently explored. This study seeks to evaluate whether immersive immersive virtual reality-based rehabilitation can be safely and practically implemented in a community psychiatric setting. The study also aims to explore preliminary effects on negative symptoms, cognitive performance, and global functioning compared with treatment as usual in a waiting-list control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 67 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals with Schizophrenia/Schizoaffective Disorder (DSM-5-TR)
  • Age 18-67 years
  • Chronic phase of illness
  • Able to provide a valid informed consent

排除标准

  • Recent substance use (less than six months)
  • Concomitant intellectual disability or neurological disorders (e.g., neurodegenerative disorders, Parkison's disease, brain cancer) that may impair the ability to undergo cognitive rehabilitation
  • With a recent (less than six weeks from the enrolling date) symptom exacerbation, hospitalization or change in pharmacotherapy
  • Acute phase of illness

研究组 & 干预措施

Immersive Virtual Reality-Based Cognitive Rehabilitation

Experimental

patients will undergo IVR-based cognitive rehabilitation sessions (about 45minutes) for 12 weeks as an adjunct to the Therapy as Usual (TAU)

干预措施: CEREBRUM VR (Device)

Waiting List

Other

The patients randomized to the waiting list arm will not undergo IVR rehabilitation, but rather continue with TAU

干预措施: Waiting List (Other)

结局指标

主要结局

Positive and Negative Syndrome Scale (PANSS)

时间窗: From enrollment to the end of treatment at 12 weeks

Total score, positive and negative symptoms, general psychopathology

次要结局

  • Global Assessment of Functioning (GAF)(From enrollment to the end of treatment at 12 weeks)
  • Digital Symbol Substitution Test (DSST)(From enrollment to the end of treatment at 12 weeks)
  • Animal Naming Test (ANT)(From enrollment to the end of treatment at 12 weeks)
  • Trial Making Test - A (TMT)(From enrollment to the end of treatment at 12 weeks)
  • Simple Reaction Time (SRT)(From enrollment to the end of treatment at 12 weeks)
  • Choice Reaction Time (CRT)(From enrollment to the end of treatment at 12 weeks)

研究者

发起方
Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验